stella
beta
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma — Stella
Recruiting
Back to Lymphoma, T-Cell trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
University of Virginia, Charlottesville, Virginia
View full record on ClinicalTrials.gov